تداخل‌های دارویی
Efgartigimod alfa + Galcanezumab
شدت: متوسط
Efgartigimod alfa and Galcanezumab: moderate interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Efgartigimod blocks the neonatal Fc receptor, which normally protects IgG from degradation. Galcanezumab is an IgG4 monoclonal antibody, so its levels could fall and its migraine-preventive effect could weaken. Clinical data for this specific combination are lacking.
معنای این تداخل به زبان ساده
Efgartigimod alfa and Galcanezumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Efgartigimod alfa belongs to Miscellaneous; Galcanezumab belongs to Central Nervous System.
چرا رخ می‌دهد
FcRn blockade by efgartigimod increases catabolism of IgG-based antibodies such as galcanezumab.
اقدام لازم
Monitor migraine control and consider a change in preventive therapy if efficacy declines. Time galcanezumab doses with awareness that efficacy may fall during efgartigimod treatment.
از داروساز چه بپرسید
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Efgartigimod alfa و Galcanezumab، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Galcanezumab
تداخلات دیگر Efgartigimod alfa
پرسش‌های متداول
Can I take Efgartigimod alfa with Galcanezumab?
MediHelp rates the interaction as moderate. Efgartigimod alfa and Galcanezumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efgartigimod blocks the neonatal Fc receptor, which normally protects IgG from degradation. Galcanezumab is an IgG4 monoclonal antibody, so its levels could fall and its migraine-preventive effect could weaken. Clinical data for this specific combination are lacking.
How serious is the interaction between Efgartigimod alfa and Galcanezumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor migraine control and consider a change in preventive therapy if efficacy declines. Time galcanezumab doses with awareness that efficacy may fall during efgartigimod treatment.
What other medicines interact with Galcanezumab?
MediHelp also lists interactions of Galcanezumab with, for example, Efgartigimod / hyaluronidase sc, Rozanolixizumab. The full list is on the Galcanezumab page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
